The global peri-implantitis treatment industry is poised for substantial growth, with a projected compound annual growth rate (CAGR) of 8.7% from 2022 to 2032. This robust expansion is expected to propel the market from its current value of US$ 2.3 billion to a projected market size of US$ 4.5 billion by 2032.
According to the National Center for Biotechnology Information (NCBI), data from an average 24-month follow-up period across the United States reveals that peri-implantitis treatments account for 21% of the market share at the implant level and 34% at the patient level. Additionally, the Centers for Disease Control and Prevention (CDC) reports that in 2019, approximately 47% of adults in the United States aged 30 years and above were afflicted by various forms of periodontal disease. Notably, this condition exhibits a higher prevalence in men, who are more susceptible, especially in cases related to underlying health conditions such as diabetes.
Request a Sample Copy of the Report Now.
https://www.futuremarketinsights.com/reports/sample/rep-gb-8437
At the same time, the fact that dental implants are costly may restrain the peri-implantitis treatment industry can’t be ignored. Also, there is a dearth of skilled specialists. Another disadvantage is that bone loss gets detected after 30% damage is done. This actually renders it difficult to start with treatment in the first instant.
Future Market Insights has walked through these facts with future perspectives in its latest market study entitled ‘Peri-Implantitis Treatment Market’. The team of analysts and consultants is there with its 360-degree research. The good part is that this research revolves around both – macros and micros.
Key Takeaways from Peri-Implantitis Treatment industry
- North America holds the largest market share. This could be attributed to growing occurrences of dental ailments coupled with well-established healthcare infrastructure all over the US. Also, with explosion of geriatric population, the peri-implantitis treatment market is likely to witness splendor in the years to come.
- The Asia-Pacific is expected to grow at the fastest rate in the peri-implantitis treatment industry. This could be credited to factors like growing numbers of market players emphasizing on launching dental implant equipment all across. Populous countries like China and India do witness an increasing frequency of Dental Implants (Dis) and oral diseases. Besides, the fact that China and India are amongst the largest tobacco-producing as well as consuming regions.
- Europe holds a significant market share in the peri-implantitis treatment industry and the scenario is expected to remain the same even in the forecast period.
Request Methodology Now!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-8437
Competitive Treatment
- Aspen Dental Management (ADMI), in November 2020, did announce that it had inked an agreement with Sun Capital partners, Inc. for acquiring CCMS (ClearChoice Management Services (providing comprehensive practice support services to network of ClearChoice Dental Implant Centers spread across the nation).
- OraCare, in January 2019, did announce launching implant post-op care system for preventing proliferation of peri-implantitis by seeing through specific compounds and organizations known for causing complications.
- Pfizer, since the year 2017, has AstraZeneca’s small molecule anti-invectives business’ commercialization and development rights.
What does the Report state?
- The research study is based on type of method (surgical treatment of peri-implantitis (mechanical debridement, laser debridement, open flap debridement, and open flap debridement with guided bone generation) and non-surgical treatment of peri-implantitis (surface debridement, antibiotics (chlorhexidine digluconate), and likewise)), and by end-user (peri-implantitis treatment in hospitals and peri-implantitis treatment in dental clinics).
- Dental implants have actually turned out to be an established therapy in dentistry, which is necessary for replacing missing teeth in diverse clinical situations. Peri-Implantitis comes across as an inflammatory reaction wherein there is a loss of supporting bone in tissues that surround a dental implant.
Key Segments Profiled in the Peri-implantitis Treatment Industry Survey
Gain the Edge with Segmented Information – Buy Now!
https://www.futuremarketinsights.com/checkout/8437
Peri-Implantitis Treatment industry by Method Type:
- Surgical Treatment of Peri-Implantitis
- Mechanical Debridement
- Laser Debridement
- Open Flap Debridement
- Open Flap Debridement with Guided Bone Generation
- Non-Surgical Treatment of Peri-Implantitis
- Surface Debridement
- Antibiotics (Chlorhexidine Digluconate)
- Others
Peri-Implantitis Treatment industry by End-User:
- Peri-Implantitis Treatment in Hospitals
- Peri-Implantitis Treatment in Dental Clinics
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
